- Home
- CELC vs RRR Comparison
CELC vs RRR Comparison
Compare CELC & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | RRR |
|---|---|---|
| Founded | 2011 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CELC | RRR |
|---|---|---|
| Price | $115.02 | $57.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $106.63 | $66.46 |
| AVG Volume (30 Days) | 538.8K | ★ 735.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ 23.32 |
| EPS | N/A | ★ 3.12 |
| Revenue | N/A | ★ $2,011,483,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | ★ N/A | $18.51 |
| Revenue Growth | N/A | ★ 3.74 |
| 52 Week Low | $7.58 | $35.09 |
| 52 Week High | $120.32 | $68.99 |
Technical Indicators
Market Signals| Indicator | CELC | RRR |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 39.83 |
| Support Level | $97.75 | $55.56 |
| Resistance Level | $114.54 | $61.64 |
| Average True Range (ATR) | 5.27 | 2.08 |
| MACD | 0.32 | -0.29 |
| Stochastic Oscillator | 67.83 | 36.14 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.